Heron Therapeutics, Inc. (HRTX) Stock Analysis

Free AI-powered analysis and research for Heron Therapeutics, Inc. stock

Sector: Healthcare

Analyze Heron Therapeutics, Inc. (HRTX) Stock

Heron Therapeutics, Inc. (HRTX) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into HRTX stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Heron Therapeutics, Inc. stock.

Analyze HRTX Now →

📰 Latest Update

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?

Tue, May 19, 2026 at 11:08 AM UTC 2 min read

Heron Therapeutics, Inc. (HRTX) saw its price target reduced to $4 by H.C. Wainwright, reflecting concerns over the company's revenue outlook and ongoing challenges in its product pipeline. This downgrade may signal to investors a more cautious approach towards Heron's growth potential and profitability, potentially impacting market sentiment and stock performance. Investors should closely monitor any developments in Heron's clinical trials and strategic initiatives moving forward.

Read full article →